Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

California Trim Clinic vs Roboclinic

California Trim Clinic
Graded #470

Lower grade

vs+12.099999999999994
Roboclinic
Graded #223

Higher grade

The verdict

Roboclinic takes it — 65.3/100 to 53.2/100.

Roboclinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRoboclinic +6
45
51
Dose & formulationRoboclinic +35
40
75
Clinical oversightRoboclinic +8
76
84
Labs & monitoringCalifornia Trim Clinic +10
63
53
FulfillmentRoboclinic +11
64
75
Contract termsRoboclinic +27
20
47
California Trim Clinic · left barRoboclinic · right bar

The numbers

MetricCalifornia Trim ClinicRoboclinic
WeighScore53.2/10065.3/100
GradeCC
Scorecard rank#470#223
SemaglutideNot disclosed$179/mo (12-month plan, compounded)
TirzepatideNot disclosed$299/mo (12-month plan, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
California Trim Clinic

Graded #470 · C

Strengths

  • Women's microdosing program specifically designed for perimenopause/menopause weight management
  • 100% virtual nationwide telehealth; medications shipped discreetly to patients' homes
  • 503A state-licensed compounding pharmacies with patient-specific prescription preparation
  • $199 initial plan covers doctor consultation, telehealth setup, and full onboarding
  • Ongoing 3-month treatment plans include compounded medication and licensed provider check-ins

Where it loses points

  • Ongoing medication pricing not publicly disclosed — revealed only after $199 intake and provider approval
  • No LegitScript certification or any other third-party accreditation visible on the site
  • No physician names or clinical leadership disclosed publicly
  • States served listed as 'nationwide' for telehealth but no state-by-state list published
  • Microdose framing uses sub-clinical doses — potentially lower weight-loss efficacy than standard GLP-1 protocols
Roboclinic

Graded #223 · C

Strengths

  • Compounded semaglutide from $179/mo and tirzepatide from $299/mo on 12-month plans
  • One all-in price bundles the provider consult, prescription, and delivery
  • Offers both injectable and oral (tablet) compounded semaglutide
  • 'Same price, every dose' means your cost does not rise as the dose increases
  • AI-first intake with board-certified provider review; no insurance necessary

Where it loses points

  • Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)
  • Individual compounding pharmacies are not named; fulfillment is routed through OpenLoop Health
  • No published per-state list; site claims 'all 50 states, restrictions apply' and gates doctor review by region
  • Refunds limited to your most recent billing cycle; none for used or partially used periods
  • Operated by BrickFi, Inc., a newer brand with limited independent track record

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard